| Text of Recommendation | Consider implementing a process by which it could proactively advise on the procurement of high-priced drugs before such drugs are purchased by non-Pharmacy Program intergovernmental agreement facilities. |
|---|---|
| Recommendation Number | 3 |
| Recommendation Status | Open |
| Significant Recommendation | No |
| Recommendation Questioned Costs | $0 |
| Recommendation Funds for Better Use | $0 |
| Additional Information | Accurate as of February 29, 2024. Also available on the DOJ OIG's website at the following link. |
| Additional Details Link |
| Submitting OIG | |
|---|---|
| Linked Report |